FORT WAYNE, IN – BioPoly, LLC has entered into an exclusive distribution agreement with Canada-based distributor, Verve Medical Products, Inc., to distribute the BioPoly® partial resurfacing family of products throughout Canada, with distribution initially taking place through the Canadian SAP. Verve Medical Products specializes in bringing medical-surgical products to Canada through its distribution and regulatory services.  Herb Schwartz, BioPoly President, said “The introduction of BioPoly’s product portfolio into North America, specifically the Canadian market, is a major accomplishment for our Company. Verve Medical Products is one of Canada’s leading medical device distributors, and we are looking forward to working with [...]

FORT WAYNE, IN – BioPoly LLC has announced that the Company has further expanded its intellectual property portfolio. The Company was granted another international patent for its partial resurfacing implants which protects the innovative implant designs. In addition to patents that cover the design of its implants, several U.S. and international patents have also been granted that address the Company’s unique BioPoly® material.  The Company’s IP portfolio, including this most recent patent, provides assurance that all aspects of its implants, material, and surgical technique are protected throughout the world. Rather than replacing the entire joint, the novel BioPoly® resurfacing implants [...]

FORT WAYNE, IN – BioPoly LLC has announced that another U.S. patent has been granted for its partial resurfacing implants which protects the innovative implant designs. The Company’s intellectual property portfolio also consists of patents that address its unique BioPoly® material.  This most recent patent further adds to the Company’s IP portfolio, providing assurance that all aspects of the implants, material, and surgical technique are protected throughout the world. Utilizing simple, reproducible minimally invasive surgical techniques, the novel BioPoly® resurfacing implants are designed to replace only the damaged cartilage of a patient’s joint rather than to replace the entire joint.  [...]

FORT WAYNE, IN – BioPoly, LLC announced today that it has fully subscribed its latest round of private equity financing of $2M.  The financing round also includes oversubscription funding of $890k.  BioPoly has now raised over $20M through its initial grants ($3.27M) and private equity offerings.  The funds received from the most recent private offering will be used to bring products to the US market as well as launch product line extension for products currently approved for sale in Europe. The Company’s partial resurfacing implants feature its unique BioPoly® material, a patented combination of hyaluronic acid (“Bio”) and ultra-high molecular [...]

FORT WAYNE, IN – BioPoly LLC has announced that another U.S. patent has been granted for its innovative BioPoly® material, which is currently being used to replace damaged cartilage in joints. Where some of the other BioPoly patents address the design of the implants, this patent family focuses on the material itself. This most recent patent, regarding material derivatives, adds to the Company’s intellectual property portfolio to provide the assurance that all aspects of the implants, material, and surgical technique are protected throughout the world. BioPoly is continuing to improve its material capabilities through its intellectual property additions (patents and [...]